Article Details
Retrieved on: 2021-06-07 12:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The regulatory agency will also announce by Monday, June 7, its decision on Alexion Pharmaceuticals, Inc.'s (NASDAQ: ALXN) supplemental new ...
Article found on: www.benzinga.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here